相关实验视频

Updated: May 17, 2025

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

lncSLERT通过通过RBM15-Mediated m6A修改向下调节HUNK表达来促进结直肠癌中的肝转移

Lin Wang¹, Liming Zhao², Jialiang Liu²

¹The State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, People's Republic of China.

OncoTargets and therapy

|May 15, 2025

概括

长非编码RNASLERT通过减少HUNK表达来促进结直肠癌肝脏转移. 针对SLERT或恢复HUNK可能为患者提供新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症转移研究癌症转移研究

背景情况:

肝转移是癌症死亡的主要原因.
结直肠癌 (CRC) 肝转移的机制尚未完全理解.
长非编码RNAs (lncRNAs) 越来越多地被认为是癌症进展中的角色.

研究的目的:

调查lncRNA SLERT在促进结直肠癌肝转移中的作用.
阐明SLERT影响结直肠癌进展的分子机制.
评估SLERT作为CRC肝转移的潜在诊断生物标志物和治疗标.

主要方法:

在CRC组织中分析SLERT表达和与患者存活时间的相关性.
在体外功能测试 (迁移,入侵) 评估SLERT对转移行为的影响.
涉及RBM15相互作用,HUNK mRNA稳定性和SLERT.的亚细胞局部化的机制研究.

主要成果:

在CRC组织中,SLERT显著上调,与患者存活率较差相关.
SLERT 敲击抑制了,而过度表达增强了CRC细胞迁移和入侵.
SLERT与RBM15相互作用,破坏HUNK mRNA的稳定,降低HUNK的表达,并促进转移.

结论:

通过通过RBM15介导的mRNA不稳定,SLERT通过降低HUNK的调节来促进CRC肝转移.
SLERT代表了CRC肝转移的潜在诊断生物标志物和治疗标.
针对SLERT或恢复HUNK可能提供新的治疗策略,以改善患者的预后.

关键词:

在CRC中,CRC就是CRC.汉克·汉克 (HUNK) 是一个伟大的球员.斯莱尔特 (SLERT) 是一个名为斯莱尔特 (SLERT) 的小镇.肝脏转移的发生.m6A 一个很好的.

更多相关视频

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

The Nucleolus

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...